Altered arginine metabolism in the hippocampus and prefrontal cortex of maternal immune activation rat offspring

Schizophrenia Research

Volumn 148, Issue 1-3, 2013, Pages 151-156

  Jing, Yu ^a   Zhang, Hu ^a   Wolff, Amy R ^a   Bilkey, David K ^a   Liu, Ping ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Agmatine; Hippocampus; L arginine; L ornithine; Prefrontal cortex; Putrescine; Schizophrenia

Indexed keywords

AGMATINE; ARGININE; ORNITHINE; PUTRESCINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBELLUM; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; HIPPOCAMPUS; IMMUNOSTIMULATION; NEUROCHEMISTRY; NONHUMAN; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROGENY; RAT; RISK FACTOR; SCHIZOPHRENIA;

ADC; AGMATINE; ARGININE DECARBOXYLASE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHETASE; ASL; ASS; DENTATE GYRUS; DG; GABA; HIPPOCAMPUS; L-ARGININE; L-ORNITHINE; MATERNAL IMMUNE ACTIVATION; MIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NO; NOS; PFC; POLY I:C; POLYINOSINIC:POLYCYTIDILIC ACID; PPI; PRE-PULSE INHIBITION; PREFRONTAL CORTEX; PUTRESCINE; SCHIZOPHRENIA; Γ-AMINOBUTYRIC ACID;

ACOUSTIC STIMULATION; ANIMALS; ANIMALS, NEWBORN; ARGININE; BODY WEIGHT; CHROMATOGRAPHY, LIQUID; CLUSTER ANALYSIS; FEMALE; HIPPOCAMPUS; INTERFERON INDUCERS; MALE; MASS SPECTROMETRY; MATERNAL EXPOSURE; POLY I-C; PREFRONTAL CORTEX; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION;

EID: 84881029903     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.06.001     Document Type: Article

References (58)

1. Baba H., Suzuki T., Arai H., Emson P.C. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. Neuroreport 2004, 15(4):677-680.
2. Baldacara L., Borgio J.G., Lacerda A.L., Jackowski A.P. Cerebellum and psychiatric disorders. Rev. Bras. Psiquiatr. 2008, 30(3):281-289.
3. Braff D.L. Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia. Curr. Top. Behav. Neurosci. 2010, 4:349-371.
4. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61(8):774-780.
5. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., Giuffrida Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8(10):766-775.
6. Cui K., Ashdown H., Luheshi G.N., Boksa P. Effects of prenatal immune activation on hippocampal neurogenesis in the rat. Schizophr. Res. 2009, 113(2-3):288-297.
7. Cui H., Nishiguchi N., Yanagi M., Fukutake M., Mouri K., Kitamura N., Hashimoto T., Shirakawa O., Hishimoto A. A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain. Schizophr. Res. 2010, 121(1-3):172-178.
8. Djordjevic V.V., Stojanovic I., Stankovic-Ferlez D., Ristic T., Lazarevic D., Cosic V., Djordjevic V.B. Plasma nitrite/nitrate concentrations in patients with schizophrenia. Clin. Chem. Lab. Med. 2010, 48(1):89-94.
9. Feil R., Kleppisch T. NO/cGMP-dependent modulation of synaptic transmission. Handb. Exp. Pharmacol. 2008, 184:529-560.
10. Fiori L.M., Turecki G. Implication of the polyamine system in mental disorders. J. Psychiatry Neurosci. 2008, 33(2):102-110.
11. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 1997, 23(3):437-458.
12. Gupta N., Jing Y., Collie N.D., Zhang H., Liu P. Ageing alters behavioural function and brain arginine metabolism in male Sprague-Dawley rats. Neuroscience 2012, 226C:178-196.
13. Halaris A., Plietz J. Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 2007, 21(11):885-900.
14. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl.) 2004, 174(1):151-162.
15. Kesner R.P., Lee I., Gilbert P. A behavioral assessment of hippocampal function based on a subregional analysis. Rev. Neurosci. 2004, 15(5):333-351.
16. Leitch B., Shevtsova O., Reusch K., Bergin D.H., Liu P. Spatial learning-induced increase in agmatine levels at hippocampal CA1 synapses. Synapse 2011, 65(2):146-153.
17. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994, 263(5149):966-969.
18. Li Q., Cheung C., Wei R., Hui E.S., Feldon J., Meyer U., Chung S., Chua S.E., Sham P.C., Wu E.X., McAlonan G.M. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One 2009, 4(7):e6354.
19. Liu P., Chary S., Devaraj R., Jing Y., Darlington C.L., Smith P.F., Tucker I.G., Zhang H. Effects of aging on agmatine levels in memory-associated brain structures. Hippocampus 2008, 18(9):853-856.
20. Liu P., Collie N.D., Chary S., Jing Y., Zhang H. Spatial learning results in elevated agmatine levels in the rat brain. Hippocampus 2008, 18(11):1094-1098.
21. Liu P., Gupta N., Jing Y., Zhang H. Age-related changes in polyamines in memory-associated brain structures in rats. Neuroscience 2008, 155(3):789-796.
22. Liu P., Jing Y., Collie N.D., Chary S., Zhang H. Memory-related changes in L-citrulline and agmatine in the rat brain. Hippocampus 2009, 19(7):597-602.
23. Liu P., Jing Y., Zhang H. Age-related changes in arginine and its metabolites in memory-associated brain structures. Neuroscience 2009, 164(2):611-628.
24. Liu P., Zhang H., Devaraj R., Ganesalingam G.S., Smith P.F. A multivariate analysis of the effects of aging on glutamate, GABA and arginine metabolites in the rat vestibular nucleus. Hear. Res. 2010, 269(1-2):122-133.
25. Liu P., Jing Y., Collie N.D., Campbell S.A., Zhang H. Pre-aggregated Abeta(25-35) alters arginine metabolism in the rat hippocampus and prefrontal cortex. Neuroscience 2011, 193:269-282.
26. Malaterre J., Strambi C., Aouane A., Strambi A., Rougon G., Cayre M. A novel role for polyamines in adult neurogenesis in rodent brain. Eur. J. Neurosci. 2004, 20(2):317-330.
27. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 2006, 26(18):4752-4762.
28. Meyer U., Feldon J., Fatemi S.H. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci. Biobehav. Rev. 2009, 33(7):1061-1079.
29. Meyer U., Feldon J., Yee B.K. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr. Bull. 2009, 35(5):959-972.
30. Meyer U., Knuesel I., Nyffeler M., Feldon J. Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology (Berl.) 2010, 208(4):531-543.
31. Patterson P.H. Maternal effects on schizophrenia risk. Science 2007, 318(5850):576-577.
32. Patterson P.H. Immune involvement in schizophrenia and autism: Etiology, pathology and animal models. Behav. Brain Res. 2009, 204(2):313-321.
33. Perez-Neri I., Ramirez-Bermudez J., Montes S., Rios C. Possible mechanisms of neurodegeneration in schizophrenia. Neurochem. Res. 2006, 31(10):1279-1294.
34. Reif A., Herterich S., Strobel A., Ehlis A.C., Saur D., Jacob C.P., Wienker T., Topner T., Fritzen S., Walter U., Schmitt A., Fallgatter A.J., Lesch K.P. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol. Psychiatry 2006, 11(3):286-300.
35. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol. Sci. 2000, 21(5):187-193.
36. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
37. Rushaidhi M., Jing Y., Zhang H., Liu P. Participation of hippocampal agmatine in spatial learning: an in vivo microdialysis study. Neuropharmacology 2013, 65:200-205.
38. Seo S., Liu P., Leitch B. Spatial learning-induced accumulation of agmatine and glutamate at hippocampal CA1 synaptic terminals. Neuroscience 2011, 192:28-36.
39. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23(1):297-302.
40. Shi L., Smith S.E., Malkova N., Tse D., Su Y., Patterson P.H. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav. Immun. 2009, 23(1):116-123.
41. Shinkai T., Ohmori O., Hori H., Nakamura J. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol. Psychiatry 2002, 7(6):560-563.
42. Smith S.E.P., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27(40):10695-10702.
43. Steinert J.R., Chernova T., Forsythe I.D. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 2010, 16(4):435-452.
44. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl.) 2001, 156(2-3):194-215.
45. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am. J. Psychiatry 2010, 167(10):1178-1193.
46. Tomiya M., Fukushima T., Watanabe H., Fukami G., Fujisaki M., Iyo M., Hashimoto K., Mitsuhashi S., Toyo'oka T. Alterations in serum amino acid concentrations in male and female schizophrenic patients. Clin. Chim. Acta 2007, 380(1-2):186-190.
47. Wallace H.M., Fraser A.V., Hughes A. A perspective of polyamine metabolism. Biochem. J. 2003, 376(Pt 1):1-14.
48. Williams K. Interactions of polyamines with ion channels. Biochem. J. 1997, 325(Pt 2):289-297.
49. Winter C., Djodari-Irani A., Sohr R., Morgenstern R., Feldon J., Juckel G., Meyer U. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int. J. Neuropsychopharmacol. 2009, 12(4):513-524.
50. Wolff A.R., Bilkey D.K. Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav. Brain Res. 2008, 190(1):156-159.
51. Wolff A.R., Bilkey D.K. The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss. Behav. Brain Res. 2010, 213(2):323-327.
52. Wu G., Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998, 336(Pt 1):1-17.
53. Yanik M., Vural H., Kocyigit A., Tutkun H., Zoroglu S.S., Herken H., Savas H.A., Koylu A., Akyol O. Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia?. Neuropsychobiology 2003, 47(2):61-65.
54. Yao J.K., Leonard S., Reddy R.D. Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr. Bull. 2004, 30(4):923-934.
55. Zaidel D.W., Esiri M.M., Harrison P.J. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am. J. Psychiatry 1997, 154(6):812-818.
56. Zolman J.F. Biostatistics: Experimental Design and Statistical Inference 1993, Oxford University Press, Oxford, UK.
57. Zuckerman L., Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J. Psychiatr. Res. 2005, 39(3):311-323.
58. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003, 28(10):1778-1789.